...
首页> 外文期刊>Transgenic Research >A survey to establish performance standards for the production of transgenic mice
【24h】

A survey to establish performance standards for the production of transgenic mice

机译:建立转基因小鼠生产性能标准的调查

获取原文
获取原文并翻译 | 示例

摘要

The generation of transgenic mice by microinjection of DNA into the pronuclei of fertilized oocytes was described in the early 1980s. A number of parameters affecting the efficiency of the technique were soon identified, including the type of DNA construct, the concentration of DNA being injected, and, most importantly, the strain of mice used for oocyte donors. Since then, hundreds of laboratories and transgenic core facilities across the world have successfully used this technique, essentially as originally described, to create thousands of new transgenic mouse lines. However, the overall procedure continues to be relatively inefficient, in terms of the number of fertilized oocytes required to produce a transgenic mouse, and variations in yields from day to day and construct to construct can be large. Consequently, core facilities often struggle to explain to their customers why a sufficient number of transgenic founders were not produced from a given construct. We believe the field (and individual facilities) would benefit from a rigorous assessment of average yields and expected variations in yields. To this end, we have initiated a survey from the International Society for Transgenic Technologies (ISTT) web site (www.transtechsociety.org), to obtain raw microinjection data from as many facilities as possible. We intend to use this data to establish performance standards for the field. Existing facilities will be able to refer to these standards in dealing with dissatisfied clients, and new facilities will be able to aim for an achievable goal. We may even be able to discover an optimum combination of factors that will allow every facility to achieve higher yields.
机译:在1980年代初期,已经描述了通过将DNA显微注射到受精卵母细胞的前核中来产生转基因小鼠。很快确定了影响该技术效率的许多参数,包括DNA构建体的类型,注入的DNA浓度,最重要的是,用于卵母细胞供体的小鼠品系。从那时起,全世界数百家实验室和转基因核心机构已经成功地使用了这项技术(基本上如最初所述)来创建了数千种新型转基因小鼠品系。然而,就产生转基因小鼠所需的受精卵母细胞的数量而言,整个过程仍然相对低效,并且每天产量和构建体之间的产量差异可能很大。因此,核心设施常常难以向其客户解释为什么没有从给定的结构中产生足够数量的转基因创始人。我们认为,该领域(和单个设施)将受益于对平均产量和预期产量变化的严格评估。为此,我们从国际转基因技术协会(ISTT)网站(www.transtechsociety.org)发起了一项调查,以从尽可能多的设施中获取原始显微注射数据。我们打算使用这些数据来建立该领域的性能标准。现有设施将能够在与不满意的客户打交道时参考这些标准,而新设施将能够达到可实现的目标。我们甚至可以发现各种因素的最佳组合,这将使每个工厂都可以实现更高的产量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号